Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
AKYXUYKRNRLTAG
|
8.3 | IC50 | 2 | — | |
BTEDJGZRXQWYSZ
|
8.3 | IC50 | 2 | — | |
CTQIQHVVPQICIK
|
8.3 | Ki | 7 | — | |
DDLZLOKCJHBUHD
|
8.3 | IC50 | 23 | — | |
FHCSBLWRGCOVPT
|
8.3 | IC50 | 4 | — | |
GJWWXUHHULUCNL
|
8.3 | IC50 | 3 | — | |
KHGPYYFCIAISBU
|
8.3 | Ki | 31 | — | |
MLJSTZOBGVWFLQ
|
8.3 | IC50 | 2 | — | |
MPCJXDLRVCJFOZ
|
8.3 | Ki | 2 | — | |
NJFATVGYCPEPCY
|
8.3 | IC50 | 2 | — | |
NSDIHUXUFJHXRA
|
8.3 | Ki | 11 | — | |
RVBOIHXTZQGXRV
|
8.3 | IC50 | 3 | Yes | |
TYNCGTPANDPODX
|
8.3 | IC50 | 4 | — | |
UJNZJFWHEHUMNG
|
8.3 | IC50 | 2 | — | |
UWZGPKLUCAHSOA
|
8.3 | IC50 | 5 | — | |
UWZGPKLUCAHSOA
|
8.3 | IC50 | 3 | — | |
WMJDKJPJZVMOIF
|
8.3 | IC50 | 2 | Yes | |
WZEMTZHNQZDUFC
|
8.3 | IC50 | 2 | — | |
XXHPNVKTJQFFNL
|
8.3 | Ki | 3 | — | |
YKPIWOGXCSQLFH
|
8.3 | IC50 | 2 | — | |
YMOZGQKWFWKZJV
|
8.3 | IC50 | 2 | — | |
YRSCDRTXWYUNBB
|
8.3 | IC50 | 4 | Yes | |
ZJQQJUGCEKHDGB
|
8.3 | IC50 | 2 | — | |
ZSPPFDDJLOSQKQ
|
8.3 | IC50 | 2 | — | |
CWSPSVWUDNKYOG
|
8.3 | Ki | 3 | — | |
REWAULXFDBKSQO
|
8.3 | IC50 | 2 | — | |
WSDKUSZMLAZIAI
|
8.3 | Ki | 3 | — | |
ZMYYFKMDWKEIBD
|
8.3 | Ki | 3 | — | |
GLEIZJBQDQWBKF
|
8.3 | Ki | 3 | — | |
KUAAAOFBHQLFAD
|
8.3 | IC50 | 2 | — | |
PQUQTSPOFKEROK
|
8.3 | IC50 | 3 | — | |
SHJYLIJHYBXPEO
|
8.3 | IC50 | 3 | — | |
FKZUETMLLHIIQA
|
8.3 | Ki | 3 | — | |
QHRXZUMETMHYMU
|
8.3 | IC50 | 2 | — | |
LAQCQSKKZIRXFW
|
8.3 | IC50 | 9 | — | |
XPFFDDFVHAFKNR
|
8.3 | IC50 | 3 | — | |
CHZARGSIIZBMPM
|
8.2 | IC50 | 3 | — | |
DHUNWVQYYPMPPG
|
8.2 | IC50 | 2 | — | |
KLSRELDSEJWOAS
|
8.2 | IC50 | 2 | — | |
KYSMDEZWWNOQLK
|
8.2 | Ki | 3 | — | |
OJSLQHGPQPNNPV
|
8.2 | Ki | 3 | — | |
ZXGJTSDTQKKJAJ
|
8.2 | Ki | 3 | — | |
DFKIWZHPSTVGSR
|
8.2 | Ki | 3 | — | |
DWGQVTNGERQBMD
|
8.2 | Ki | 3 | — | |
HFCIUXUUWFLDQF
|
8.2 | IC50 | 2 | — | |
MHBKUCFDNISLNC
|
8.2 | IC50 | 2 | — | |
PKBMKQHUGHPUML
|
8.2 | IC50 | 2 | — | |
PQOGJESGKNBNIP
|
8.2 | IC50 | 2 | — | |
CCLYDGMRCYZTFK
|
8.2 | IC50 | 2 | — | |
OYNBEDDKSIPEQC
|
8.2 | IC50 | 3 | — |